statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Verve Therapeutics, Inc. for potential violations of federal securities laws Wolf Haldenstein Adler Freeman & Herz LLP...

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Verve Therapeutics, Inc. for potential violations of federal securities laws

Verve Therapeutics, Inc. (NASDAQ:VERV - Get Free Report) insider Joan Nickerson sold 1,514 shares of Verve Therapeutics stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold...

Insider Selling: Verve Therapeutics, Inc. (NASDAQ:VERV) Insider Sells 1,514 Shares of Stock

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Verve Therapeutics price target lowered by $16 at Stifel, here's why

Verve Therapeutics Stock Remains A Hold After VERVE-101 Enrollment Pause...

Verve Therapeutics Stock Remains A Hold After VERVE-101 Enrollment Pause

Heart-1 clinical trial demonstrated LDL-C reduction of up to 73% at 0.45 mg/kg of VERVE-101 Company to pause enrollment in Heart-1 clinical trial following asymptomatic Grade 3 transient ALT...

Verve Therapeutics Announces Updates on its PCSK9 Program

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Verve Therapeutics, Inc...

Attention Verve Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

For the last three days, A.I.dvisor has detected that VERV's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Verve Therapeutics (VERV, $12.79) Aroon Indicator entered a Downtrend on April 01, 2024.

LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve...

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Verve Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing...

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Investors eyeing a purchase of Verve Therapeutics Inc (VERV) shares, but tentative about paying the going market price of 13.11/share, might benefit from considering selling puts among the...

Commit To Purchase Verve Therapeutics At $10, Earn 22.4% Annualized Using Options

Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.

Watchers	1,576
52-Wk Low	$5.84
52-Wk High	$21.42

Volume	1.6M
52-Wk High	$21.42
52-Wk Low	$5.84

VERV Verve Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals